close
Add to watchlist
BSD Medical Corp (BSDM)
BSD Medical Corporation develops, manufactures, markets, and services medical systems that deliver precision-focused radio frequency (RF) or microwave energy into diseased sites of the body, heating them to specified temperatures as required by various medical therapies. The company develops the technology and products required to approach thermal ablation and hyperthermia cancer therapy through various techniques, which include thermal ablation that ablates soft tissues at high temperatures through focused microwave energy; superficial hyperthermia, which non-invasively treats cancerous tumors located within a few centimeters of the surface of the body, such as melanoma and recurrent breast cancer; internal or interstitial hyperthermia that treats tumors in combination with internal radiation therapy by inserting tiny microwave antennae that deliver hyperthermic microwave energy to tumors through the same catheters used to deliver radioactive materials to tumors for radiation therapy; and deep hyperthermia, which non-invasively treats tumors located deep within the body, including various problematic cancer sites located in the pelvis, abdomen, and chest areas. It offers MicroThermX-100 Microwave Ablation System to ablate soft tissue percutaneously, laparoscopically, or surgically; BSD-500 systems used to deliver either superficial or interstitial hyperthermia therapy or both; and BSD-2000 family of products that non-invasively deliver hyperthermic microwave energy to cancerous tumors, as well as BSD-2000/3D and BSD-2000/3D/MR. The company serves clinics, hospitals, and institutes that treat cancer worldwide. BSD Medical Corporation was founded in 1978 and is headquartered in Salt Lake City, Utah.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 2.17 |
| Volume | 29461 |
| Volume Avg | 60923 |
| 52 Week High | 4.79 |
| 52 Week Low | 2.00 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -0.20 |
| EPS change Q/Q | -25% |
| EPS change Q/Q Yr ago | -44.44% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -79.17% |
| REV change Q/Q | -20% |
| REV change Q/Q Yr ago | -33.33% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |